Home / Drug shortages / Rifampin Injection

Rifampin Injection — FDA Drug Shortage

Current — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Rifampin Injection (injection) from Sanofi-Aventis U.S. LLC with status Current. The shortage was first posted on 02/17/2021. Reported reason: Discontinuation of the manufacture of the drug

Shortage Details

Status
Current
Company
Sanofi-Aventis U.S. LLC
Package NDC
0068-0597-01
Dosage Form
Injection
Presentation
Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)
Initial Posting
02/17/2021
Revised Date

Reason

Discontinuation of the manufacture of the drug

FDA data resources